Your child's pediatrician just said "we're recommending genetic testing" and handed you a referral to a geneticist. You nodded, took the paper, and now you're sitting in your car wondering what you just agreed to.

You're not alone in that confusion. In early 2026, the American Academy of Pediatrics updated its guidance on genetic testing for children with global developmental delay and intellectual disability. The change makes whole exome sequencing or whole genome sequencing the first-tier recommendation, not a later step if other tests fail. That's a shift, and it means parents are hearing these terms at appointments without preparation.

Here's what genetic testing means, why the AAP changed its guidance, and what to expect if your child's doctor recommends it.

What Genetic Testing Is (and Isn't)

Genetic testing looks at your child's DNA to identify changes (called variants) that might explain developmental delays or intellectual disability. It's not a test for one condition. It's a search across thousands of genes for patterns that match known genetic conditions.

About 40% of children with global developmental delay or intellectual disability have a genetic cause. That doesn't mean testing always finds an answer. Plenty of results come back unclear or negative. But when it does identify a variant, it can change the medical plan, connect families to condition-specific resources, and sometimes clarify what to expect as your child grows.

Genetic testing doesn't predict your child's future. It doesn't measure severity. It tells you whether there's a genetic explanation for what you're already seeing.

The Three Types You'll Hear About

Your geneticist will probably mention three options: chromosomal microarray (CMA), whole exome sequencing (WES), and whole genome sequencing (WGS). They're ordered by how much of the genome they examine.

Chromosomal microarray looks for large deletions or duplications: missing or extra chunks of DNA. It's been the standard first test for years. It catches conditions like DiGeorge syndrome or Angelman syndrome, where a piece of a chromosome is visibly altered. It doesn't read individual genes letter by letter, so it misses smaller changes.

Whole exome sequencing reads the protein-coding parts of the genome: about 2% of your child's total DNA, but the 2% where most disease-causing variants sit. It catches point mutations and small changes that CMA can't see. WES finds a diagnosis in roughly 30-40% of cases where CMA came back negative.

Whole genome sequencing reads everything: coding regions, regulatory regions, the spaces between genes. It's the most comprehensive test, but also the most expensive and the hardest to interpret. Most of the genome's function isn't well understood yet, so WGS generates more uncertain findings than WES does.

Until this year, the standard path was CMA first, then WES if CMA didn't find anything. The 2026 AAP update flips that. Now the recommendation is to go straight to WES or WGS, skipping CMA unless there's a clinical reason to start there.

Why the AAP Changed Its Guidance

The change comes down to diagnostic yield and cost. WES finds an answer in more cases than CMA does, and the price gap between the two has narrowed enough that insurance increasingly covers WES as a first test. Starting with the more sensitive test means fewer families go through multiple rounds of testing, fewer kids need repeat blood draws, and more families get answers sooner.

The AAP reviewed evidence showing that when WES is used as a first-tier test for unexplained developmental delays, it identifies a genetic diagnosis in 36-53% of cases. That's significantly higher than CMA's yield, which sits around 15-20%. The updated guidance reflects what genetic testing can do now, not what it could do a decade ago.

What Trio Testing Means

If your geneticist recommends trio testing, that means they want DNA samples from your child and both biological parents. You'll get a call asking you and your partner to come in for blood draws. The lab needs your DNA to filter out inherited variants, which represent what's normal for your family, from what might explain your child's delays.

Most of us carry dozens of genetic variants that don't cause problems. Trio testing helps the lab distinguish between a variant your child inherited from you and a new variant that appeared for the first time in your child. Inherited variants are usually harmless since you're unaffected. New variants are more likely to be relevant.

Trio testing increases the diagnostic rate by about 10% compared to testing your child alone. It also reduces the number of uncertain findings, which matters when you're trying to make sense of results.

If one parent isn't available for any reason, whether separation, adoption, or donor conception, the test can still run. You'll just get more variants flagged as "uncertain significance" because the lab has less information to work with.

Understanding VUS Results

A VUS is a variant of uncertain significance. It means the lab found a change in your child's DNA, but they don't have enough evidence to say whether it's causing the delays or just a normal variation. VUS results are common. They're frustrating, but they're not failures.

When you get a VUS, you're in a waiting pattern. The lab will sometimes recommend follow-up testing: checking other family members, doing functional studies, or retesting in a few years as databases improve. Some VUS results get reclassified as pathogenic or benign as more research comes in. Some stay uncertain indefinitely.

A VUS doesn't change your child's care plan. You don't treat based on uncertain findings. You keep doing what you're already doing with therapies, specialists, and monitoring, and you check back periodically to see if the classification has changed.

What a Positive Finding Means

If testing identifies a pathogenic variant, you'll get a report naming the genetic condition. That's the starting point, not the endpoint.

A positive result opens doors. You can connect with condition-specific organizations, find research trials, locate specialists with direct experience, and sometimes adjust medical monitoring based on known risks. Some genetic conditions come with increased risk for heart issues, seizures, or other medical concerns that warrant closer follow-up.

It doesn't predict your child's developmental trajectory. Two kids with the same genetic variant can look very different. Genetic conditions have wide variability, and your child is still the same person they were before you had a name for the variant.

A positive result also sometimes clarifies recurrence risk if you're planning another pregnancy. Genetic counselors walk through those numbers with you: what the chance is that a future child would inherit the same variant, and what testing options exist during pregnancy.

What Happens If Results Are Negative

A negative result means testing didn't find a genetic explanation. That's not the same as "nothing's wrong." It means the cause isn't detectable with the test you ran, or it's not genetic at all.

Developmental delays have non-genetic causes: prematurity, birth complications, environmental exposures, or causes medicine hasn't identified yet. A negative genetic test doesn't rule those out. It just closes the genetic door.

Some families retest years later as technology improves. WGS might catch something WES missed. New variants get added to databases. What comes back negative today might not stay that way.

Your child's care doesn't hinge on finding a genetic answer. Therapies, educational plans, and medical support continue regardless. The genetic test is one tool, not the only one.

Before You Go to the Appointment

Write down your questions before the geneticist visit. You'll forget half of them once the appointment starts. Bring a partner, family member, or friend who can take notes. Genetic counseling sessions cover a lot of ground quickly, and it's easy to lose details.

Ask about turnaround time. Results typically take 8-12 weeks, but that varies by lab and insurance. Ask what happens if they find a VUS. Ask whether they're recommending trio testing and why. Ask how results get delivered. Some clinics call, some send a letter, some schedule a follow-up appointment.

If cost is a concern, ask about financial assistance before the blood draw. Many labs have programs that cap out-of-pocket costs for families who qualify. Insurance coverage for WES and WGS is improving, but denials still happen. Knowing the backup plan before you're holding a bill helps.

The Test Doesn't Define Your Child

Genetic testing is a tool. It's one piece of information in a much larger picture. Whether results come back positive, negative, or uncertain, your child is still the same kid you're raising. The test doesn't change who they are or what they need from you.

What it can do is give you language, connect you to a community, and sometimes open access to resources you didn't know existed. Those are real benefits. But they're not guarantees, and they're not the only path forward.

You're doing this because you want answers. Sometimes you'll get them. Sometimes you won't. Either way, you'll keep moving.